Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Mucinex SE vs Vicks Syrup in Healthy Subjects
NCT03644095Phase 1Completed
- Sponsor
- Reckitt
- Start
- Jan 2009
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Mucinex SE in cough (2 arms), sponsored by Reckitt. Primary endpoints: Maximum Observed Plasma Concentration, Area Under Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration and 5 more. Started Jan 2009; status: completed.
02
Drugs
Mucinex SE
03
Conditions
cough
Beyond the preview
Go deeper on NCT03644095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644095.